Seth Harmon - 12 Sep 2023 Form 3 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
Exhibit 24 - Power of Attorney Senior Vice President of Finance
Signature
/s/ Lara Meisner, Attorney-in-Fact for Seth Harmon
Issuer symbol
VRDN
Transactions as of
12 Sep 2023
Net transactions value
$0
Form type
3
Filing time
19 Sep 2023, 16:30:14 UTC
Next filing
13 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VRDN Stock Option (Right to Buy) 12 Sep 2023 Common Stock 175,000 $24.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on June 1, 2024 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date.

Remarks:

Exhibit 24 - Power of Attorney Senior Vice President of Finance